Pharmaceutical Industry Declares FDA Guidelines Too Unclear

Companies within the pharmaceutical industry recently expressed their need for more precise, clear-cut guidelines from the Food and Drug Administration (FDA). Without a more definitive set of protocol measures, certain pharmaceutical companies have threatened to cease development of some treatment medications.

In a statement made last Thursday, the chairman of the board of Pharmaceutical Research and Manufacturers of America (PhRMA) reported that they may stop working to establish new treatments for diseases such as obesity and diabetes. Instead, they are considering turning their focus to developing medications for cancer treatments – a branch of medicine that is notorious for being more open in its acceptance of adversity in the face of testing treatments.

The statement seems to stem from a general concern within the pharmaceutical industry about a company's ability to effectively predict the FDA's measurements of drug safety. Unable to understand the specific risks and benefits that the FDA uses to determine safety , it is difficult for pharmaceutical development companies to produce medications for more common diseases that are unwilling to take risks in the drugs prescribed to patients.

While the pharmaceutical industry may be blaming the unclear guidelines issued by the FDA, it would appear that the true frustration lies in the fact that adverse events are continuing to arise as they test and develop medications for the general public. Of course, the FDA will not approve this type of adversity, as it directly subjects patients to medical risks and health hazards. However, for pharmaceutical companies this is the last thing they want to hear. Rather than working to rectify the potential dangers of the drugs they are producing, some businesses are willing to call it quits and simply go in another direction.

This will in no way solve the problem, particularly for those who have already been harmed by a dangerous drug and those who may go without the medications they need if the industry stops developing new drugs. If you or someone you love was injured or suffered a medical condition as a result of a defective drug, then you are entitled to the representation that a pharmaceutical injury attorney can provide as you move forward and take legal action.

At Arnold & Itkin, LLP we have successfully handled the complexity of drug injury cases throughout the nation, at both the state and federal levels. With our help, you can fight to hold the responsible parties liable for your ill health. Contact a pharmaceutical injury lawyer from our firm to learn more about how we can supply you with knowledgeable legal representation in the face of your injury or medical condition.